This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Frank K. Thorp, MD, PhD

JAMA. 1986;255(5):645-647.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

It has been recognized for some time that the traditional methods of treating type I diabetes mellitus (insulin-dependent diabetes mellitus) with a program of one or two daily insulin injections and diet and exercise planning are quite imperfect. With the advent of home blood glucose—monitoring techniques and glycosylated hemoglobin determinations, it is evident that many persons with diabetes have a degree of hyperglycemia sufficient to contribute to development of devastating longterm complications. Ultimately, it is hoped that advances in the field of islet cell transplantation or pancreas transplantation will allow more physiologic control of blood glucose levels. In the interim, efforts to improve insulin administration have resulted in the development of a myriad of electromechanical pump devices. These insulin infusion devices are designed to mimic the natural pattern of insulin release by providing both a continuous, variable small supply of insulin and extra boluses of insulin prior to eating. Now . . . [Full Text PDF of this Article]

Author Affiliations
Wyler Children's Hospital The University of Chicago Medical Center

Footnotes
Address editorial communications to the Editor, 535 N Dearborn St, Chicago, IL 60610.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?